News Image

NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

By Mill Chart

Last update: Apr 12, 2024

In this article we will dive into DOXIMITY INC-CLASS A (NYSE:DOCS) as a possible candidate for growth investing. Investors should always do their own research, but we noticed DOXIMITY INC-CLASS A showing up in our strong growth, ready to breakout screen, which makes it worth to investigate a bit more.

Understanding NYSE:DOCS's Growth

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NYSE:DOCS scores a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 21.62% over the past year.
  • The Earnings Per Share has been growing by 106.72% on average over the past years. This is a very strong growth
  • The Revenue has grown by 16.57% in the past year. This is quite good.
  • DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.27% yearly.
  • DOCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.19% yearly.
  • Based on estimates for the next years, DOCS will show a quite strong growth in Revenue. The Revenue will grow by 11.62% on average per year.

ChartMill's Evaluation of Health

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:DOCS scores a 9 out of 10:

  • An Altman-Z score of 23.71 indicates that DOCS is not in any danger for bankruptcy at the moment.
  • DOCS has a better Altman-Z score (23.71) than 94.87% of its industry peers.
  • There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • DOCS has a Current Ratio of 8.03. This indicates that DOCS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 8.03, DOCS belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • A Quick Ratio of 8.03 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS's Quick ratio of 8.03 is amongst the best of the industry. DOCS outperforms 92.31% of its industry peers.

What does the Profitability looks like for NYSE:DOCS

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NYSE:DOCS has achieved a 9:

  • The Return On Assets of DOCS (13.76%) is better than 100.00% of its industry peers.
  • DOCS's Return On Equity of 15.92% is amongst the best of the industry. DOCS outperforms 97.44% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 15.40%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 4.83%.
  • With an excellent Profit Margin value of 29.39%, DOCS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DOCS has grown nicely.
  • Looking at the Operating Margin, with a value of 34.75%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • DOCS's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 88.94%, DOCS belongs to the best of the industry, outperforming 97.44% of the companies in the same industry.

Looking at the Setup

In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the extent of consolidation in the stock based on multiple short-term technical indicators. Currently, NYSE:DOCS has a 7 as its setup rating:

DOCS has a bad technical rating, but it does show a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 26.89. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 26.07, a Stop Loss order could be placed below this zone.

Every day, new Strong Growth stocks can be found on ChartMill in our Strong Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of DOCS

Check the latest full technical report of DOCS for a complete technical analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

DOXIMITY INC-CLASS A

NYSE:DOCS (4/29/2024, 1:33:00 PM)

24.19

+0.37 (+1.55%)

DOCS News

News Imagean hour ago - Wolf Haldenstein Adler Freeman & Herz LLPClass Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for Northern District of California against Doximity, Inc.

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a securities class action lawsuit has been filed in the United...

News Image8 hours ago - Bernstein Liebhard LLPDOXIMITY, INC. (NYSE: DOCS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
News Imagea day ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such...

News Image2 days ago - The Rosen Law Firm, P.A.ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock...

News Image2 days ago - Kessler Topaz Meltzer & Check, LLPDoximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against...

News Image3 days ago - Kahn Swick & Foti, LLCDOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

News Image3 days ago - NewMediaWireDOCS LOSS ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Image3 days ago - TheNewswire.comDOCS LOSS ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

WHY: NEW YORK, NY - (NewMediaWire) - April 26, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 17, 2024.

News Image3 days ago - Robbins LLPDOCS Class Action Alert: Robbins LLP Reminds Doximity, Inc. Shareholders of the Lead Plaintiff Deadline in the Class Action Lawsuit
News Image3 days ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors
News Image4 days ago - Bragar Eagel & SquireBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, and Doximity Innovations and Encourages Investors to Contact the Firm
News Image4 days ago - DoximityDoximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024
DOCS Links
Follow us for more